Matthew Weiss
Patterson Belknap Webb & Tyler LLP
Articles
Federal Circuit Axes Amgen Antibody Patents, Finding Lack of Enablement
USA - February 18 2021 The Federal Circuit considered its 35 U.S.C. § 112 enablement case law and found that “the enablement inquiry for claims that include functional…
FDA Approves Breyanzi®—A New Biologic for Treating Large B-Cell Lymphoma
USA - February 9 2021 On February 5, 2021, the FDA approved Juno Therapeutics, Inc.’s Breyanzi® (lisocabtagene maraleucel) for “treatment of adult patients with relapsed…
2021 Biosimilar Approval and Litigation Update
USA - February 1 2021 The last two years saw the launch of several biosimilars. Looking ahead to 2021, several others may be on the horizon. In 2019-2020, the FDA approved…
Rehearing Denied in Federal Circuit Hatch-Waxman Venue Case
USA - January 28 2021 The Federal Circuit has spoken. In a per curiam opinion, it denied Valeant’s petition for rehearing by the panel and rehearing en banc. A case…
Judge Ramos Finds Forum Selection Clause of NDA Implicates Confidentiality and Not IP Rights and Allows IPRs to Proceed
USA - January 26 2021 On January 19, 2021, United States District Judge Edgardo Ramos (S.D.N.Y.) denied Kannuu Pty Ltd. (“Kannuu”)’s motion for preliminary injunction and…
